Back
MediPharm Labs Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
47
MEDIF
MediPharm Labs
Last Price:
0.05
Seasonality Move:
-2.25%
Buy
78
AUPH
Aurinia Pharmaceuticals
Last Price:
8.28
Seasonality Move:
30.05%
Sell
47
MediPharm Labs (MEDIF)
is a Sell
Is MediPharm Labs a Buy, Sell or Hold?
- The current MediPharm Labs [MEDIF] share price is $0.05. The Score for MEDIF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- MEDIF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.38. The Score for AUPH is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MEDIF Stock Price Chart
What is MediPharm Labs's stock price today?
-
The MediPharm Labs share price today is $0.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEDIF is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight selling pressure.
MEDIF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 52.33 | Buy |
| Chaikin Money Flow: | 27645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.05 - 0.05) | Buy |
| Bollinger Bands (100): | (0.05 - 0.05) | Buy |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 72.16 | Buy |
| Chaikin Money Flow: | -482985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.86 - 7.84) | Buy |
| Bollinger Bands (100): | (5.68 - 7.3) | Buy |
MEDIF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.05 | Buy |
| 20-day SMA: | 0.05 | Buy |
| 50-day SMA: | 0.05 | Buy |
| 200-day SMA: | 0.05 | Sell |
| 8-day EMA: | 0.05 | Buy |
| 20-day EMA: | 0.05 | Buy |
| 50-day EMA: | 0.05 | Buy |
| 200-day EMA: | 0.05 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.86 | Buy |
| 20-day SMA: | 7.45 | Buy |
| 50-day SMA: | 7.18 | Buy |
| 200-day SMA: | 6.07 | Buy |
| 8-day EMA: | 8 | Buy |
| 20-day EMA: | 7.6 | Buy |
| 50-day EMA: | 7.16 | Buy |
| 200-day EMA: | 6.72 | Buy |
MediPharm Labs Earnings Growth & MEDIF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
MediPharm Labs Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||